Autodesk Inc. (ADSK) had a pretty good morning. Shares of the design software company jumped more than 6% in premarket trading after delivering quarterly results that handily beat Wall Street's expectations.
The company reported third-quarter revenue of $1.85 billion, up 18% year-over-year and comfortably ahead of the $1.81 billion analysts were expecting. Adjusted earnings came in at $2.67 per share, crushing the consensus estimate of $2.50 per share. When you beat on both the top and bottom lines like that, investors tend to notice.
Autodesk shares climbed 6.1% to $312.50 in premarket action, setting up what could be a strong trading day for the software maker.
But Autodesk wasn't the only stock making moves before the opening bell. Here's a look at some of the other notable premarket movers.
The Winners
Mobile-Health Network Solutions (MNDR) absolutely exploded higher, surging 45.4% to $2.76 in premarket trading. The Singapore-based company submitted a filing on Monday with the Securities and Exchange Commission to increase its at-the-market offering capacity to $2.26 million from $1.25 million.
Inno Holdings Inc. (INHD) jumped 29.5% to $0.35 in premarket trading after dropping 44% on Tuesday. INNO Digital recently signed a memorandum of understanding with Megabyte Solutions to jointly develop applications of Web3 technology.
KALA BIO Inc. (KALA) gained 24.1% to $0.79 in premarket action. Last week, the Massachusetts-based biopharmaceutical company entered into a Securities Purchase Agreement with investor David Lazar to raise up to $6 million through a private placement, according to a Securities and Exchange Commission Form 8-K filing.
Wellgistics Health Inc. (WGRX) rose 18.2% to $0.65 in premarket trading. Datavault AI granted Wellgistics Health an exclusive license to its proprietary smart-contract intellectual property for use in Wellgistics' pharmacychain and einsteinrx platforms.
Urban Outfitters Inc. (URBN) climbed 17.4% to $80.19 in premarket trading after the apparel retailer reported third-quarter EPS and sales that topped analyst estimates.
Boqii Holding Ltd. (BQ) advanced 11% to $1.95 in premarket trading after declining 4% on Tuesday.
Nomadar Corp. (NOMA) rose 9.6% to $7.99 in premarket trading after falling 10% on Tuesday.
Mesoblast Ltd. (MESO) gained 6.8% to $17.15 in premarket trading. Jefferies analyst David Stanton on Tuesday upgraded Mesoblast from Hold to Buy.
Petco Health and Wellness Company Inc. (WOOF) gained 8.1% to $3.21 in premarket trading after the pet retailer reported better-than-expected third-quarter EPS results.
The Losers
Nutanix Inc. (NTNX) had a rough morning, tumbling 16.8% to $48.86 in premarket trading. The cloud computing company reported worse-than-expected first-quarter financial results and cut its FY26 sales guidance below estimates. That's not the combination investors want to see.
Biomx Inc. (PHGE) declined 13.2% to $5.00 in premarket trading after the company issued an update on BX004 Phase 2b trial in cystic fibrosis.
Kaixin Holdings (KXIN) shares dipped 12.1% to $0.18 in premarket trading. Kaixin announced a 1-for-30 reverse stock split, effective December 1.
Deswell Industries Inc. (DSWL) fell 11.5% to $3.28 in premarket trading.
Pharmacyte Biotech Inc. (PMCB) fell 9% to $0.81 in premarket trading. PharmaCyte Biotech shares had jumped 37% on Tuesday after the company announced monetization of its stake in Femasys.
Jiayin Group Inc. ADR (JFIN) dipped 7.8% to $6.83 in premarket trading.
Zscaler Inc. (ZS) fell 7.2% to $269.00 in premarket trading as the cybersecurity company reported financial results for the first quarter.
Ambarella Inc. (AMBA) fell 6.7% to $84.84 in premarket trading after posting quarterly results.
Pagerduty Inc. (PD) dipped 5.8% to $14.30 in premarket trading after the company reported mixed third-quarter financial results and lowered its FY26 sales guidance below estimates.
HP Inc. (HPQ) fell 5.7% to $22.94 in premarket trading after the company issued first-quarter EPS guidance with a midpoint below estimates. Even solid companies can struggle when the forward outlook disappoints.
